Solarise

**Solarise** is an investigational injectable botanical anticancer drug candidate developed by G&E Herbal Biotechnology. Public sponsor material identifies it as Solarise Injection and describes nonclinical evaluation in squamous cell head and neck cancer; other public pipeline reporting identifies female genital neoplasms and head and neck neoplasms as development indications. Solarise appears to be a derivative program associated with G&E's SR-T100 botanical anticancer development platform, but Solarise's exact active composition, molecular targets, and detailed mechanism of action have not been publicly disclosed. ([en.geherbs.com](https://en.geherbs.com/show/solarise-injection.htm))

Other names

SolariseSolarise InjectionSolarise針劑